Literature DB >> 15016322

Influence of hospital procedure volume on ovarian cancer survival in Japan, a country with low incidence of ovarian cancer.

Akiko Ioka1, Hideaki Tsukuma, Wakiko Ajiki, Akira Oshima.   

Abstract

The survival of ovarian cancer patients has been reported to be superior at hospitals with a high volume of operations. A population-based study was carried out to assess whether this is true in Japan, where the incidence rate is relatively low as compared with other developed countries. The Osaka Cancer Registry's data were used to investigate associations between hospital procedure volume and survival of ovarian cancer patients. Hospitals were ranked according to the number of operations for ovarian cancer performed per year (high/medium/low/very low). Survival analysis was restricted to the reported 2450 cases who lived in Osaka Prefecture (except for Osaka City) diagnosed in 1975-1995, or those who resided in Osaka City in 1993-1995, since active follow-up data on vital status 5 years after the diagnosis were available. The relative 5-year survival for all ovarian cancer cases was 38.8%, and the survival was higher with greater hospital volume (22.3% / 34.2% / 46.2% / 55.0%). After adjustment for age, histologic type and cancer stage by the Cox regression model, patients receiving care in very-low-volume hospitals were seen to have a 60% higher risk of death than patients receiving care in high-volume hospitals (P < 0.01). Although some limitations existed in this study, the results indicated that further centralization of operative treatment in high-volume hospitals might improve survival of ovarian cancer patients in Japan.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15016322     DOI: 10.1111/j.1349-7006.2004.tb02208.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  8 in total

Review 1.  Is It Time to Centralize Ovarian Cancer Care in the United States?

Authors:  Renee A Cowan; Roisin E O'Cearbhaill; Ginger J Gardner; Douglas A Levine; Kara Long Roche; Yukio Sonoda; Oliver Zivanovic; William P Tew; Evis Sala; Yulia Lakhman; Hebert A Vargas Alvarez; Debra M Sarasohn; Svetlana Mironov; Nadeem R Abu-Rustum; Dennis S Chi
Journal:  Ann Surg Oncol       Date:  2015-10-28       Impact factor: 5.344

2.  Ovarian cancer in the United States: contemporary patterns of care associated with improved survival.

Authors:  William A Cliby; Matthew A Powell; Noor Al-Hammadi; Ling Chen; J Philip Miller; Phillip Y Roland; David G Mutch; Robert E Bristow
Journal:  Gynecol Oncol       Date:  2014-10-29       Impact factor: 5.482

Review 3.  Centralisation of services for gynaecological cancer.

Authors:  Yin Ling Woo; Maria Kyrgiou; Andrew Bryant; Thomas Everett; Heather O Dickinson
Journal:  Cochrane Database Syst Rev       Date:  2012-03-14

4.  Observed-to-expected ratio for adherence to treatment guidelines as a quality of care indicator for ovarian cancer.

Authors:  Valerie B Galvan-Turner; Jenny Chang; Argyrios Ziogas; Robert E Bristow
Journal:  Gynecol Oncol       Date:  2015-09-24       Impact factor: 5.482

5.  Being treated in higher volume hospitals leads to longer progression-free survival for epithelial ovarian carcinoma patients in the Rhone-Alpes region of France.

Authors:  Marius Huguet; Lionel Perrier; Olivia Bally; David Benayoun; Pierre De Saint Hilaire; Dominique Beal Ardisson; Magali Morelle; Nathalie Havet; Xavier Joutard; Pierre Meeus; Philippe Gabelle; Jocelyne Provençal; Céline Chauleur; Olivier Glehen; Amandine Charreton; Fadila Farsi; Isabelle Ray-Coquard
Journal:  BMC Health Serv Res       Date:  2018-01-04       Impact factor: 2.655

6.  Hospital Surgical Volume and 3-Year Mortality in Severe Prognosis Cancers: A Population-Based Study Using Cancer Registry Data.

Authors:  Yukari Taniyama; Takahiro Tabuchi; Yuko Ohno; Toshitaka Morishima; Sumiyo Okawa; Shihoko Koyama; Isao Miyashiro
Journal:  J Epidemiol       Date:  2020-01-11       Impact factor: 3.211

7.  Hospital volume and postoperative 5-year survival for five different cancer sites: A population-based study in Japan.

Authors:  Sumiyo Okawa; Takahiro Tabuchi; Toshitaka Morishima; Shihoko Koyama; Yukari Taniyama; Isao Miyashiro
Journal:  Cancer Sci       Date:  2020-02-03       Impact factor: 6.716

8.  Adherence to French and ESGO Quality Indicators in Ovarian Cancer Surgery: An Ad-Hoc Analysis from the Prospective Multicentric CURSOC Study.

Authors:  Martinez Alejandra; Witold Gertych; Christophe Pomel; Gwenael Ferron; Amelie Lusque; Martina Aida Angeles; Eric Lambaudie; Roman Rouzier; Naoual Bakrin; Francois Golfier; Olivier Glehen; Michel Canis; Nicolas Bourdel; Nicolas Pouget; Pierre-Emmanuel Colombo; Frédéric Guyon; Jacques Meurette; Denis Querleu
Journal:  Cancers (Basel)       Date:  2021-03-30       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.